Open AccessAnalgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis
Author(s) -
Pasero Gp,
Di Munno O
Publication year - 2011
Publication title -
reumatismo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.294
H-Index - 25
eISSN - 2240-2683
pISSN - 0048-7449
DOI - 10.4081/reumatismo.2002.238
Subject(s) - medicine , lornoxicam , diclofenac , rheumatoid arthritis , analgesic , crossover study , piroxicam , arthritis , anesthesia , pharmacology , alternative medicine , pathology , placebo
To evaluate the therapeutic action and safety of lornoxicam, a new non steroidal anti-inflammatory drug, in 2 oral daily dose regimens of 8 and 16 mg in comparison with oral diclofenac 150 mg/day in patients with rheumatoid arthritis.